Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1091 of 5804
-
Blood test may decide who needs surgery for rectal cancer
Knowledge-focused Not yet recruitingThis is a phase 2 pragmatic study to examine the utility of ctDNA-informed treatment management for participants with early-stage rectal cancer using the Signatera Genome assay. The primary aims are to 1) assess pathologic complete response (path CR) in the ctDNA informed managem…
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Pharmacists to the rescue: new study aims to protect kidneys in diabetes patients without a family doctor
Disease control Recruiting nowType 2 diabetes is the leading cause of chronic kidney disease, which can result in serious complications such as kidney failure and heart disease. Although effective medications exist to slow the progression of kidney damage, they are often underused in primary care, particularl…
Phase: NA • Sponsor: Nova Scotia Health Authority • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a simple steroid course save lives in severe respiratory infections?
Disease control Not yet recruitingMulticenter, parallel-group, randomized clinical trial comparing the administration of systemic corticosteroids at a dose equivalent to 40 mg of prednisolone per day for 7 days vs no corticosteroid administration among adults hospitalized with severe acute respiratory infection a…
Phase: PHASE4 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can a japanese ARDS drug fix deadly clots in septic shock?
Disease control Not yet recruitingSepsis-induced disseminated intravascular coagulation (DIC) is a severe complication occurring in one-third of patients with septic shock, for which no specific treatment currently exists. It results from excessive systemic activation of coagulation and impaired fibrinolysis, lea…
Phase: PHASE2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
AI virtual coach aims to cut breast cancer risk through lifestyle changes
Prevention Recruiting nowBreast cancer (BC) is the most commonly diagnosed cancer in women worldwide, with early-onset cases increasing due to genetic and lifestyle factors. Traditional prevention strategies have shown limited effectiveness, creating the need for innovative approaches. The MELIORA projec…
Phase: NA • Sponsor: Harokopio University • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
New injection plus radiation shows promise against cervical cancer
Disease control Recruiting nowThis is a seamless Phase 1/2 study consisting of two components. Phase 1 component is a dose-escalation, single arm, open label study in 10 patients to evaluate the safety and tolerability of KRC 01. Phase 2 component is a randomized, open label, controlled, multi-center study in…
Phase: PHASE1 • Sponsor: Kortuc, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Hot flash drug may unlock heart health secrets in midlife women
Knowledge-focused Recruiting nowThe goal of this clinical trial is to learn if neurokinin-1/neurokinin-3 receptor antagonist elinzanetant improves blood vessel health in women with moderate to severe hot flashes. The main questions it aims to answer is does neurokinin-1/neurokinin-3 receptor antagonist elinzane…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Could coiling an artery in the head stop migraines?
Disease control Not yet recruitingThis single-site, open-label pilot study evaluates the safety, feasibility, and potential durability of the TEMMA procedure (Targeted Embolization for Migraine Management), an endovascular treatment strategy targeting meningeal arterial contributors to migraine. Adults aged 18-60…
Phase: NA • Sponsor: Cortex Neurovascular • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New smart system aims to catch dangerous blood pressure drops earlier
Diagnosis Not yet recruitingOrthostatic hypotension (OH) has a high incidence rate of 30%-50% in the elderly and populations with neurodegenerative diseases. The resulting cerebral hypoperfusion significantly increases the risk of cerebral ischemia, falls, and cognitive decline. Traditional OH diagnosis pri…
Sponsor: Xuanwu Hospital, Beijing • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Could a tiny zap ease endometriosis agony? new trial aims to find out.
Symptom relief Not yet recruitingEndometriosis is a condition that often causes pelvic pain, particularly during menstruation but also continuously and over long periods. Pharmacological treatments are only moderately effective or are associated with adverse effects. In this context, the search for non-pharmacol…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Brain training offers hope for epilepsy patients who Don't respond to drugs
Disease control Not yet recruitingA large proportion of patients (approximately 30%) with drug-resistant epilepsy are not eligible for surgical treatment. The alternatives that can be offered to reduce the frequency of seizures are neuromodulation (vagus nerve stimulation (VNS), deep brain stimulation (DBS), or t…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
PET scan could sharpen radiation for returning brain tumors
Disease control Recruiting nowReciDOPA is a phase II, single-stage randomized, multicenter, prospective trial assessing the efficacy of an irradiation protocol based on Intensity-modulated radiation therapy with simultaneous-integrated boost guided by FDOPA-PET in patient with recurrent glioblastoma.
Phase: PHASE2 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Say 'Bend Arm' to recover: Voice-Activated robot may boost stroke rehab
Symptom relief Not yet recruitingThis study aims to investigate whether combining "motor imagery" (the mental visualization of movement) with robotic exoskeleton therapy can improve upper limb recovery in stroke patients. Conventional robotic therapy often involves passive movement driven by the machine. In this…
Phase: NA • Sponsor: Taipei Hospital, Ministry of Health and Welfare • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New radiation applicator aims to treat rectal cancer without surgery
Disease control Not yet recruitingRectal cancer is a common type of cancer and an important cause of illness and death worldwide. In 2020, cancers of the colon and rectum were the fourth most common cancers globally, and about one third of these cases were rectal cancer. Surgery is the main treatment for rectal c…
Phase: PHASE2 • Sponsor: Siriraj Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a simple protein infusion prevent deadly Re-Bleeding in cirrhosis patients?
Disease control Not yet recruitingThe objective of this randomized control clinical trial is to learn the role of albumin in patients with acute variceal bleed. The trial will include all adult patients with acute variceal bleeding and cirrhosis presenting to Medical Gastroenterology department at KGMU, Lucknow, …
Phase: PHASE3 • Sponsor: King George's Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New blood test could replace risky prenatal procedures
Diagnosis Not yet recruitingSince the discovery of a small fraction of circulating cell-free fetal DNA (ccffDNA) in the blood of the mother, non-invasive prenatal diagnosis (NIPD) techniques using a simple blood sample have been developed to 1) screen for chromosomal abnormalities, 2) diagnose fetal sex, an…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
New Stent-Graft for aortic aneurysm tested in Real-World registry
Disease control Recruiting nowObjective To pragmatically collect and analyze patient-level clinical, procedural, and outcome data from participating centers in Italy and Poland on the use of the PERCUTEK Tycheseal™ stent-graft system for the endovascular repair of abdominal aortic aneurysms. The study aims to…
Sponsor: American Heart of Poland • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
Can a memory pill combo shield your brain from radiation?
Disease control Not yet recruitingThe study investigators are testing to see if patients receiving radiation treatment for brain cancer along with raloxifene plus memantidine take longer to develop memory issues. The study will include anyone over the age of 18 who will be treated with radiation for brain cancer…
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New eye implant could rival standard glaucoma surgery
Disease control Recruiting nowThe goal of this randomized controlled clinical trial is to learn whether two minimally invasive bleb-forming glaucoma implants can effectively treat adult patients with open-angle glaucoma who require surgical lowering of intraocular pressure (IOP). Specifically, the study evalu…
Phase: NA • Sponsor: Medical University of Bialystok • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Heart attack drug may fix 'Hidden' vessel damage
Disease control Not yet recruitingDespite the success of restoration of epicardial blood flow by the primary percutaneous coronary intervention (PPCI), approximately one half of patients with ST-segment elevation myocardial infarction (STEMI) have failed myocardial reperfusion, namely microvascular dysfunction. P…
Phase: PHASE4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC